HIV/AIDS Clinical Trial
Official title:
A Pilot Study to Improve Functional Health Health Status in Minority Women Living With HIV
HIV is no longer a death sentence, and with adherence to Rapid High Activity Antiretroviral
(HAART) protocol women with HIV can achieve a normal life expectancy. In New Jersey there are
11,724 (32.9%) women living with HIV with Essex county in the lead, and they come they come
from lowest social strata and educational level and are often single mothers. The purpose of
this study is test three study interventions: a cognitive health promotion intervention, a
guided imagery intervention and combination of both interventions.
The Significance of the study is to improve the functional health and protocol adherence, to
better enable women with HIV to achieve a normal life expectancy. The Methodology is an
intervention study that uses a classic four group pretest post-test experimental design with
random assignment, and the subjects for the study will be 80 women living with HIV. The
interventions will be delivered within a three-week time frame followed by post testing at
the end of the third week in Newark,New Jersey. The results of this study will be used as
preliminary data to support a grant proposal to be submitted to the National Institutes of
Health. The Results of this study are important as they will support improved health function
and adherence to treatment protocols for marginalized poor women with HIV to achieve outcomes
on par with men.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 30, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Women participants diagnosed with HIV - Must speak and write in English Exclusion Criteria: - Women participants with debilitating complications - Women participants with Cognitive Impairment |
Country | Name | City | State |
---|---|---|---|
United States | Seton Hall University, College of Nursing | Nutley | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Seton Hall University |
United States,
Barrett EA. Power as knowing participation in change: what's new and what's next. Nurs Sci Q. 2010 Jan;23(1):47-54. doi: 10.1177/0894318409353797. — View Citation
Caroselli C, Barrett EA. A review of the power as knowing participation in change literature. Nurs Sci Q. 1998 Spring;11(1):9-16. Review. — View Citation
Hansell PS, Hughes CB, Caliandro G, Russo P, Budin WC, Hartman B, Hernandez OC. Boosting social support in caregivers of children with HIV/AIDS. AIDS Patient Care STDS. 1999 May;13(5):297-302. — View Citation
Hansell PS, Hughes CB, Caliandro G, Russo P, Budin WC, Hartman B, Hernandez OC. The effect of a social support boosting intervention on stress, coping, and social support in caregivers of children with HIV/AIDS. Nurs Res. 1998 Mar-Apr;47(2):79-86. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CD4 Counts | Cells in human body measure response immune system to infection | Measured at the baseline | |
Primary | CD4 Counts | Cells in human body measure response immune system to infection | Measured 21 days after the baseline | |
Primary | Viral Load | Sero blood assessment of amount of HIV virus. | At the baseline | |
Primary | Viral Load | Sero blood assessment of amount of HIV virus | Twenty-one days following the baseline | |
Primary | SF-36v2 Health Survey | Functional Health from the participants perspective | At the baseline | |
Primary | SF-36v2 Health Survey | Functional Health from the participants perspective | Twenty-one days after the baseline | |
Primary | Power as Knowing Participation in Change (PKPCT) | Subjects Power Profile to Create Change | At the Baseline. | |
Primary | Power as Knowing Participation in Change (PKPCT) | Subjects Power Profile to Create Change | Twenty-one days after the baseline. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|